August 28, 2013 8:25am EDT
Download as PDF
Provides Broader Access to Israeli Investors for Shares already
listed on NYSE and TASE under Ticker Symbol OPK
MIAMI--(BUSINESS WIRE)--
OPKO Health, Inc. (NYSE: OPK), a multi-national biopharmaceutical and
diagnostics company, today announced that OPKO's common stock, which
began trading on the Tel-Aviv Stock Exchange ("TASE") on August 21,
2013, will be included, effective October 6, 2013, in the following
major TASE indices: Tel Aviv 25, Tel Aviv 100, Tel Aviv Composite, Tel
Aviv Biomed, and Tel Aviv BlueTech-50.
“OPKO’s inclusion in these major TASE indices expands our exposure to
Israel’s vibrant investment community and its large and sophisticated
investors,” commented Dr. Phillip Frost, OPKO’s Chairman and Chief
Executive Officer. “Our participation in these major indices conveys
broader coverage through index-based instruments, exchange traded notes,
funds and specialized funds, while providing easier access to
institutional and private investors within the Israeli market."
OPKO will remain subject to the rules and regulations of the NYSE and of
the U.S. Securities and Exchange Commission. Trading on the TASE occurs
on Sunday from 9:45 AM to 4:30 PM Israel time and on Monday through
Thursday from 9:45 AM to 5:30 PM Israel time, except on TASE trading
holidays. Through the amendment to Israel's Securities Law 5728-1968,
that took effect in October 2000, U.S.-listed companies may dual-list on
the TASE without any additional regulatory requirements. TASE links to
the U.S. markets via a direct link to DTC, a subsidiary of the
Depository Trust & Clearing Corporation, which facilitates the trading
of dually-listed securities.
ABOUT OPKO HEALTH, INC.
OPKO is a multinational biopharmaceutical and diagnostics company that
seeks to establish industry leading positions in large, rapidly growing
markets by leveraging its discovery, development and commercialization
expertise and novel and proprietary technologies. For more information,
visit http://www.opko.com .
SAFE HARBOR STATEMENT
This press release includes forward looking statements, within the
meaning of the Private Securities Litigation Reform Act of 1995, which
are subject to risk and uncertainties that could cause actual results to
differ materially from those anticipated. Such statements may relate to
OPKO's plans, objectives and expected financial and operating results,
including statements regarding our ability to expand our exposure to the
Israeli investment community and increase interest in OPKO among
Israel's large and sophisticated institutional investors. The words
"may," "could," "would," "will," "believe," "anticipate," "estimate,"
"expect," "intend," "plan," and similar expressions or variations
thereof are intended to identify forward-looking statements. Investors
are cautioned that any such forward-looking statements are not
guarantees of future performance and involve risks and uncertainties,
many of which are beyond OPKO's ability to control. The risks and
uncertainties that may affect forward looking statements include, but
are not limited to: currency fluctuations, global economic and political
conditions, marketing demand for OPKO's products and services, long
sales cycles, new product development, assimilating future acquisitions,
maintaining relationships with customers and partners, and increased
competition, as well as the risk we may not complete the acquisition of
PROLOR Biotech, Inc. For more details about the risks and uncertainties
related to OPKO's business, refer to OPKO's filings with the Securities
and Exchange Commission. OPKO undertakes no obligation to publicly
update or revise any forward looking statements, whether as a result of
new information, future events or otherwise.
OPKO Heath, Inc.
Steve D. Rubin, +1-305-575-4100
Executive
Vice President — Administration
or
Juan F. Rodriguez,
Chief Financial Officer
Source: OPKO Heath, Inc.
Released August 28, 2013
email Email Alerts
location_city Company Profile
contact_page Contacts
rss_feed RSS News Feed
account_tree Sitemap
Apply on OPKO Health (Ireland)’s careers page